Search Results - "Evans, Myron K."
-
1
Ybx1 fine-tunes PRC2 activities to control embryonic brain development
Published in Nature communications (13-08-2020)“…Chromatin modifiers affect spatiotemporal gene expression programs that underlie organismal development. The Polycomb repressive complex 2 (PRC2) is a crucial…”
Get full text
Journal Article -
2
Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer
Published in Molecular oncology (01-06-2015)“…Cancer cells often have increased levels of reactive oxygen species (ROS); however, acquisition of redox adaptive mechanisms allows for evasion of ROS-mediated…”
Get full text
Journal Article -
3
Author Correction: Ybx1 fine-tunes PRC2 activities to control embryonic brain development
Published in Nature communications (25-01-2023)Get full text
Journal Article -
4
Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity
Published in Nature communications (17-09-2021)“…PTEN promoter hypermethylation is nearly universal and PTEN copy number loss occurs in ~25% of fusion-negative rhabdomyosarcoma (FN-RMS). Here we show Pten…”
Get full text
Journal Article -
5
Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma
Published in Neoplasia (New York, N.Y.) (01-09-2023)“…Constitutional mismatch repair deficiency (CMMRD) is a cancer predisposition syndrome associated with the development of hypermutant pediatric high-grade…”
Get full text
Journal Article -
6
Mn porphyrin in combination with ascorbate acts as a pro-oxidant and mediates caspase-independent cancer cell death
Published in Free radical biology & medicine (01-03-2014)“…Resistance to therapy-mediated apoptosis in inflammatory breast cancer, an aggressive and distinct subtype of breast cancer, was recently attributed to…”
Get full text
Journal Article -
7
XIAP Regulation by MNK Links MAPK and NFκB Signaling to Determine an Aggressive Breast Cancer Phenotype
Published in Cancer research (Chicago, Ill.) (01-04-2018)“…Hyperactivation of the NFκB pathway is a distinct feature of inflammatory breast cancer (IBC), a highly proliferative and lethal disease. Gene expression…”
Get full text
Journal Article -
8
Abstract 1007: Elucidating a role for the translation initiation factor, eIF4G1, in resistance to therapy in inflammatory breast cancer (IBC)
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…Abstract Inflammatory breast cancer (IBC) is a highly invasive and aggressive breast cancer with relatively low survival rates compared with other locally…”
Get full text
Journal Article -
9
Abstract 5107: Targeting CTPS1 and nucleotide biosynthesis pathways as a novel therapeutic approach in MYC-amplified medulloblastoma
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Abstract Although leukemia is the leading pediatric oncology diagnosis, brain tumors are the leading cause of pediatric cancer-related death. Medulloblastoma…”
Get full text
Journal Article -
10
Abstract LB-015: XIAP induction by the MAPK-eIF4G1 pathway drives NFκB activation in inflammatory breast cancer growth and therapeutic resistance
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract Inflammatory breast cancer (IBC) is the most lethal, distinct form of breast cancer, however, the basis for its aggressiveness and rapid acquisition…”
Get full text
Journal Article -
11
Abstract P6-14-05: A novel link between anti-apoptotic signaling, NFκB, and SMAD7 in IBC pathobiology
Published in Cancer research (Chicago, Ill.) (01-05-2015)“…Abstract Background: Inflammatory breast cancer (IBC) has the highest lethality amongst all subtypes of breast cancer and develops rapid therapeutic…”
Get full text
Journal Article -
12
Abstract 1667: Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children with no improvements in treatment options for RMS patients over the past…”
Get full text
Journal Article